Arcametric
Researcher brief
Clinical evidence infrastructure
2026

Research-facing brief

A Structured Evidence Layer for Interventional Mental Health

Interventional mental health is already generating valuable real-world clinical data. Arcametric structures it at the point of care so it can be compared, analyzed, and exported without moving patient names into the shared system.

1. Document each step in the arc of care, without ever sharing a patient's name.

Arcametric is the documentation and outcomes layer for interventional mental health. It runs beside the records your clinic already keeps, structures the full arc of care, and keeps patient names, dates of birth, and contact details in the clinic.

Two design choices drive the research value: how much of the care arc is structured, and where patient identity stops. The rest of this brief follows from those two facts.

The Arc of Care: preparation, treatment/dosing, integration support, outcomes, and reporting
How much of care it captures. Arcametric documents the full arc of care, from intake through the treatment phases to follow-up, outcomes, and reporting, structured at every step.
PLATFORM ARCHITECTURE Zero-PHI by design Identity stays in your clinic. Only coded references cross. YOUR CLINIC Identity lives here Patient name Date of birth Contact details Your existing records Held in the systems you already use. Never sent to us. Name, date of birth, contact details STOPS HERE Coded reference THE BOUNDARY ARCAMETRIC The data boundary PT-4471 Patient reference, scoped to your site RxNorm Substance administered LOINC Standard measure, scored over time MedDRA Safety term, kept on its own record SNOMED Where care was delivered T+00:42 Timing, measured from session launch Structured fields handle information that repeats. Narrative remains available when something needs explanation. Row-level security is verified at the database, not promised in a policy. WHAT COMES OUT For the clinic Progress summary, letter of medical necessity, referral summary, audit and compliance record. For research De-identified structured export across the full arc, with safety and experiential records kept separate.
Where identity stops. Patient names, dates of birth, and contact details stay in the clinic. Only coded references cross the boundary.

2. Interventional mental health is generating real-world data that current systems can't analyze.

Interventional mental health is generating real-world clinical data at scale. Most of it is not computable.

Sessions are documented in free-text notes, entered into EHR fields designed for visit-based primary care, or recorded inconsistently across providers and protocols. Assessment instruments are administered but not scored in structured form. Adverse events are narrated, not coded. Follow-up outcomes are tracked informally or not at all.

The result is a rapidly expanding clinical practice with almost no structured, analyzable real-world evidence to draw from. The problem is not a shortage of sessions. It is a shortage of infrastructure designed to capture what those sessions produce in a form that supports analysis.

3. General-purpose records turn a continuous care arc into disconnected, unstructured data.

General-purpose records were built for visit-based, diagnosis-driven care. Five gaps recur across interventional mental health settings.

Where it breaksWhat happens
StructureGeneral-purpose EHRs were designed for visit-based, diagnosis-driven care. The preparation, dosing, and integration arc does not map onto standard encounter templates, so clinicians adapt with free text, which produces no computable output.
IdentityPatient identity is embedded throughout standard clinical records, which makes downstream de-identification a retroactive process with variable reliability. Systems designed to store identifiers cannot easily produce an evidence layer that removes them.
Longitudinal linkageTracking across sessions requires explicit subject-linking architecture. Standard encounter-based documentation does not maintain that link in a computable form, so cross-session analysis requires manual chart reconstruction.
SafetyAdverse-event patterns, substance interactions, vital-sign deviations, and protocol variances are captured narratively. They cannot be queried programmatically or aggregated across providers for signal detection.
ExportThe output of existing documentation workflows is PDF notes and static charts. There is no structured export format suitable for registry submission, IRB data packages, or outcome-correlation analysis.

4. Pool evidence without pooling identities.

Arcametric is designed as a structured clinical intelligence layer, not a general-purpose records system. Its architecture makes specific decisions oriented toward producing computable data from routine clinical documentation, without asking practitioners to do extra data-entry work for research purposes.

The core design intent is to make structured documentation part of routine clinical work, so the same record can also support evidence generation without becoming a separate research data-entry project.

  1. Structured input controls capture the variables intended for comparison across preparation, treatment/dosing, and integration. Substance, route, and dose are captured against governed reference tables rather than typed as unstructured text.
  2. De-identified subject linking connects sessions longitudinally without direct patient identifiers in the shared data model. The treating organization keeps the identity-to-reference mapping locally.
  3. Structured assessment administration produces scored, timestamped records from instruments administered within the platform. Scores are stored as discrete values, not narrative summaries.
  4. Structured safety events are captured against governed terminology references. Adverse events, interaction flags, and protocol deviations can be queried instead of being trapped in free-text narrative.
  5. Export-oriented design produces structured data outputs from routine documentation, reducing the reconstruction and cleaning required downstream.

De-identified architecture opens up new possibilities.

Each design choice carries through, row by row, from the architecture to what it means and what it makes possible.

The architectureWhat that meansWhat it makes possible
Zero-PHI by design: the shared clinical data model has no field intended to hold a patient name.Patient names, dates of birth, and contact details remain outside the shared clinical data model.You reduce centralized identity exposure because the shared system does not store patient names.
Your clinic keeps the only identity-to-reference mapping in its own systems.Arcametric does not hold the identity-to-reference mapping.You keep control of the information that connects a de-identified reference back to a person.
Comparable clinical variables are coded at the point of documentation, with governed reference vocabularies applied at the source.The same defined variable can be recorded consistently across sessions, practitioners, and sites.You can compare outcomes across eligible records as data accumulates, while patient identity remains outside the shared system.
Routine clinical documentation is structured from the start.Routine documentation produces structured records that can be analyzed without reconstructing them from narrative notes.You can export structured evidence from routine work without creating a separate research data-entry workflow.

5. Aggregate, standardize, and export your evidence.

Each capability below turns routine documentation into structured, computable evidence.

CapabilityWhat it enables
Longitudinal patient trajectoryStructured session data linked by a de-identified subject reference across the full care arc, so cross-session outcome analysis does not require manual chart reconstruction.
Adverse-event analysisStructured adverse-event capture with severity, timing, and session context, and can be queried across subjects with shared exposure variables.
Assessment outcome correlationStructured scores from administered instruments correlated against session variables such as substance, dose, route, and phase, supporting pre and post analysis without reconstruction.
Network benchmarkingBenchmarking across eligible records and participating sites, with comparison value increasing as additional outcomes are logged and network participation grows.
Structured export packagesStructured exports that can support downstream statistical analysis and preparation of IRB or registry data packages, subject to each study or registry's requirements.
Reference table coverageSubstances, routes, and clinical interactions governed against reference tables, with crosswalk mapping toward recognized external standards.

Architecture note. The de-identified design reduces certain centralized identifier risks, but it does not by itself constitute a certified de-identification method under HIPAA Safe Harbor or Expert Determination standards. Research teams should evaluate the data-governance posture with their own IRB and legal counsel before relying on Arcametric outputs for regulated research purposes.

6. Review Arcametric from the research lens that matters to you.

AudienceWho it serves
Research teams and investigatorsPrincipal investigators, research coordinators, and data scientists evaluating existing or prospective interventional mental health data infrastructure for study design or real-world evidence review.
IRB and ethics evaluatorsBoards and ethics committees assessing data-capture systems used in interventional mental health, particularly around de-identification architecture and subject-linking methodology.
Outcomes researchersResearchers modeling cost-effectiveness, safety, or population-level outcomes who require structured, computable longitudinal data rather than chart abstractions.
Registry and standards bodiesOrganizations developing data standards, reporting frameworks, or registry protocols who want to evaluate a production data model against emerging field standards.

7. Verify the model, the boundary, and the exports.

Review areaKey questions
Data model architectureHow are sessions, subjects, assessments, and safety events structured? What are the entity relationships, and how is longitudinal linkage maintained?
De-identification postureWhat identifiers are excluded from the shared model by design? What stays in the local organization's control? What legal review is complete, and what remains institution-specific?
Reference table governanceWhat external standards are the substance, route, and interaction reference tables aligned to? Where do crosswalk gaps exist, and what is the remediation roadmap?
Export format and completenessWhat computable outputs are available today, and in what format? What fields are present or missing relative to registry or IRB submission requirements?
Benchmark methodologyHow are network comparisons constructed? What are the inclusion criteria, opt-in governance, and suppression rules for small-cell disclosure risk?

Next step: review the architecture with us

If you want to evaluate Arcametric for research, registry, or evidence-generation use, the next step is a technical briefing. We will walk through the data model, de-identification architecture, current capability state, export formats, and known limitations directly.

Next, see the Clinical Data Taxonomy and Export Dictionary for the de-identified data model, the variable dictionary, and the structured export formats.

Contact: hello@arcametric.com · arcametric.com

Arcametric

Arcametric
arcametric.com
© 2026 Arcametric